Hyperprolactinemia and mammary prostheses. A report of eight cases.
Eight young women developed clinical manifestations of hyperprolactinemia after the application of bilateral methylpolixolosane mammary prostheses. Elevated serum levels of prolactin were present in all cases. Treatment with bromocriptine or methergoline corrected the excessive prolactin production and associated symptoms. The pathophysiology of this syndrome is unexplained as yet.
V
V
Ruíz-Velasco
D000328:Adult; D000858:Anovulation / Q000209:etiology; D001940:Breast / Q000601:surgery*; D001971:Bromocriptine / Q000627:therapeutic use; D005260:Female; D005687:Galactorrhea / Q000209:etiology; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy / Q000209:etiology*; D007247:Infertility, Female / Q000209:etiology; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology*; D011247:Pregnancy; D011388:Prolactin / Q000097:blood; D019736:Prostheses and Implants; D012833:Siloxanes
D012833:Siloxanes; D001971:Bromocriptine; D011388:Prolactin